FDA-Australia cGMP agreement

FDA and the Therapeutic Goods Administration of Australia signed a cooperative arrangement Oct. 11 allowing the exchange of information on current Good Manufacturing Practice inspections of human pharmaceutical facilities between the U.S. and Australia. The agreement is part of international harmonization efforts. While this is the first signed agreement, discussions are ongoing with Europe and Japan